Details for Patent: 10,632,150

Which drugs does patent 10,632,150 protect, and when does it expire?

Patent 10,632,150 protects POTASSIUM PHOSPHATES and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 10,632,150

Title:	Potassium phosphates composition for injection
Abstract:	Disclosed herein is a sterile composition for injection comprised of potassium phosphates having no visible particulate. Also disclosed herein is a manufacturing process for the sterile composition and its use.
Inventor(s):	Thomas; H. Greg (Flowery Branch, GA), LeVasseur; Richard (Flowery Branch, GA), Kiel; Jeffrey S. (Flowery Branch, GA), Pipho; Anthony Reid (Winterville, NC)
Assignee:	CMP Development LLC (Farmville, NC)
Application Number:	16/389,181
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Process;

Drugs Protected by US Patent 10,632,150

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cmp Dev Llc	POTASSIUM PHOSPHATES	potassium phosphate, dibasic; potassium phosphate, monobasic	SOLUTION;INTRAVENOUS	212121-001	Sep 19, 2019		RX	Yes	Yes			Y			POTASSIUM PHOSPHATES INJECTION IS INDICATED AS A SOURCE OF PHOSPHORUS IN INTRAVENOUS FLUIDS TO CORRECT HYPOPHOSPHATEMIA IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER

International Family Members for US Patent 10,632,150

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
World Intellectual Property Organization (WIPO)	2020081118